(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMA CRISTALINA DE TEGAVIVINT, MÉTODO DE PREPARAÇÃO E USO DA MESMA

Em AnáliseInvention PatentPCT · US2021052610

Application data

Number

112023005832

Type

Invention Patent

Filing

09/29/2021

Publication

05/02/2023

PCT

US2021052610

Progress at the INPI

  1. Filing09/29/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 09/29/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 05/02/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ITERION THERAPEUTICS, INC.

US

Inventors

D. O. (pessoa física)

US

G. S. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

17/037,287 · 09/29/2020

Abstract

FORMA CRISTALINA DE TEGAVIVINT, MÉTODO DE PREPARAÇÃO E USO DA MESMA. A presente invenção se refere a formas cristalinas de (9E,10E)-2,7-bis((3,5-dimetilpiperidin-1-il)sulfonil)antraceno-9,10-diona dioxima, composições farmacêuticas que compreendem a forma cristalina, processos para preparar a forma cristalina e métodos de uso para os mesmos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

05/02/2023

RPI 2730

Alteração de dados cadastrais

#1.1

04/11/2023

RPI 2727

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.